TY - JOUR
T1 - Long-term response to fractionated radiotherapy of presumed optic nerve sheath meningioma
AU - Lesser, Robert L.
AU - Knisely, Jonathan P.S.
AU - Wang, Silas L.
AU - Yu, James B.
AU - Kupersmith, Mark J.
PY - 2010
Y1 - 2010
N2 - Background/aims: To review the long-term results of treatment of optic nerve sheath meningiomas (ONSMs) with conformal radiotherapy. Methods: Eleven patients with presumed ONSM were treated with fractionated conformal radiotherapy using 45-54 Gy in 25-30 fractions and followed for more than 5 years. Affected eye visual acuity in logMAR notation, colour vision, threshold perimetry, mean deviation (dB) and imaging were studied before and after treatment. Analysis: Included adverse effects of treatment and the frequency of affected eye maintained or improved vision. Results: There were nine women and two men with a mean age of 45.3. Vision or field loss was the most common presentation. All had abnormal MR imaging. The follow-up period after radiotherapy was 61-156 months (mean 89.6). Visual acuity was unchanged or improved in 10 patients (91%). The average difference between pretreatment and final logMAR visual acuity was 0.08, while the average difference in visual-field mean deviation was -4.63 dB. The radiographic appearance of the tumours was stable in size in nine patients and decreased in two. No major side effects from radiation were seen. Conclusions: Vision, MRI and complication outcomes are favourable for using fractionated conformal radiotherapy for ONSM.
AB - Background/aims: To review the long-term results of treatment of optic nerve sheath meningiomas (ONSMs) with conformal radiotherapy. Methods: Eleven patients with presumed ONSM were treated with fractionated conformal radiotherapy using 45-54 Gy in 25-30 fractions and followed for more than 5 years. Affected eye visual acuity in logMAR notation, colour vision, threshold perimetry, mean deviation (dB) and imaging were studied before and after treatment. Analysis: Included adverse effects of treatment and the frequency of affected eye maintained or improved vision. Results: There were nine women and two men with a mean age of 45.3. Vision or field loss was the most common presentation. All had abnormal MR imaging. The follow-up period after radiotherapy was 61-156 months (mean 89.6). Visual acuity was unchanged or improved in 10 patients (91%). The average difference between pretreatment and final logMAR visual acuity was 0.08, while the average difference in visual-field mean deviation was -4.63 dB. The radiographic appearance of the tumours was stable in size in nine patients and decreased in two. No major side effects from radiation were seen. Conclusions: Vision, MRI and complication outcomes are favourable for using fractionated conformal radiotherapy for ONSM.
UR - http://www.scopus.com/inward/record.url?scp=77952133586&partnerID=8YFLogxK
U2 - 10.1136/bjo.2009.167346
DO - 10.1136/bjo.2009.167346
M3 - Article
C2 - 19965820
AN - SCOPUS:77952133586
SN - 0007-1161
VL - 94
SP - 559
EP - 563
JO - British Journal of Ophthalmology
JF - British Journal of Ophthalmology
IS - 5
ER -